Heart Disease Trial, Recruiting (NCT07016477)

Heart Disease Trial, Recruiting NCT07016477 Sponsor: Semmelweis University Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07016477 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People for whom a transcatheter aortic valve implantation (a minimally invasive heart valve procedure) has been recommended by their doctor
People for whom both a CT scan and an invasive coronary angiography (a procedure to look at the heart's arteries) have been recommended as part of their care
People who have no medical reasons preventing them from having a CT scan with contrast dye
People who are able to understand and sign a consent form agreeing to take part

Who may not be able to join:

People who are pregnant or currently breastfeeding
People with severe chronic kidney disease (where the kidneys are not filtering well enough, as measured by a specific blood test result)
People who are currently undergoing active treatment for cancer
People who have a medical condition that means the heart valve procedure itself is not suitable for them, and therefore the related scans would not be needed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pál Maurovich-Horvat, MD, PhD, DSc, Semmelweis University

Phone: +3614591500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07016477

Sponsor: Semmelweis University

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +3614591500

More information: https://clinicaltrials.gov/study/NCT07016477

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People for whom a transcatheter aortic valve implantation (a minimally invasive heart valve procedure) has been recommended by their doctor
People for whom both a CT scan and an invasive coronary angiography (a procedure to look at the heart's arteries) have been recommended as part of their care
People who have no medical reasons preventing them from having a CT scan with contrast dye
People who are able to understand and sign a consent form agreeing to take part

Who may not be able to join:

People who are pregnant or currently breastfeeding
People with severe chronic kidney disease (where the kidneys are not filtering well enough, as measured by a specific blood test result)
People who are currently undergoing active treatment for cancer
People who have a medical condition that means the heart valve procedure itself is not suitable for them, and therefore the related scans would not be needed

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Semmelweis University

Registry

ClinicalTrials.gov

Start date

1 June 2024

Est. completion

30 May 2029

Where this trial is recruiting

🇩🇪 Germany 🇭🇺 Hungary 🇳🇱 Netherlands 🇨🇭 Switzerland 🇺🇸 United States

Primary endpoints

Diagnostic Accuracy of Ultra-High Resolution Photon-Counting Detector Coronary Computed Tomography Angiography (UHR PCD-CT CCTA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov